Waldencast plc

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.

The submission of this form does not create an attorney-client relationship.

Investigation Details

On July 5, 2023, after the market closed, Waldencast filed a current report with the U.S. Securities and Exchange Commission in which it disclosed, among other things that certain financial statements of Obagi, a skin care company that Waldencast had acquired, could no longer be relied upon because Waldencast expected to restate those financial statements.

On this news, the price of Waldencast stock fell over 10%, closing at $6.63 on July 6, 2023.